We are the voice of the home and alternate site infusion
community and the patients we serve
NHIA is fighting to ensure that federal policy supports equitable access to the full range of home infusion therapies.
Home Infusion providers: support our advocacy efforts and receive data to benchmark your performance by participating in NHIF's Benchmarking program, which helps track key data on patient outcomes and more.
Learn more about the data behind the safety and efficacy of home-based infusion as well as associated research in Infusion Journal, NHIF's peer-reviewed, scholarly publication.
NHIA represents and advances the interests of organizations that provide infusion and alternate site pharmacy services and products to the entire spectrum of home-based patients. In doing so, we consider the provision of cost-effective and high quality medical care to patients undergoing infusion therapy to be of the utmost importance.
As part of the association’s efforts to advance the industry, we monitor and advocate on a range of important health care issues. We are focused on clinical and business best-practices that may be subject to legislation, regulation, accreditation, practices of health plans/third party payers, and more. Learn more about the issues impacting the home and specialty infusion field and how to use your voice to advance the industry.
NHIA President & CEO Connie Sullivan responds to recent alarmist news stories based on flawed research about CLABSI surveillance in home infusion.
“Misleading stories about the risks of home infusion have real consequences and may result in fewer patients eventually having access to these essential services.”
NHIA is disappointed by the characterization of a recent study regarding infection control in home infusion, which the association asserts is not at all reflective of home infusion therapy standards and practices.
On December 2, 2022, NHIA sent a follow-up letter to Defense Health Agency, including a copy to Express Scripts (ESI), sharing recent updates on efforts by ESI to narrow the TRICARE pharmacy network and urging the DOD to reinstate all home infusion providers to the ESI network to prevent disruptions in home infusion access for TRICARE beneficiaries.
A diverse group of 30 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across the care continuum, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 2652/H.R. 5067) and increase access to home infusion therapy for Medicare beneficiaries.
© 2023, National Home Infusion Association
All Rights Reserved by NHIA
